Literature DB >> 3745985

Alpha-interferon: differential suppression of colony growth from human erythroid, myeloid, and megakaryocytic hematopoietic progenitor cells.

E M Mazur, W J Richtsmeier, K South.   

Abstract

The effect of varying concentrations of interferon-alpha (IFN-alpha) on the in vitro colony growth from all single-lineage human hematopoietic colony-forming progenitor cells was evaluated. IFN-alpha was tested at concentrations of 0, 2, 20, and 200 U/ml in optimally stimulated bone marrow cultures from each of 4 volunteer donors. Substantial donor-to-donor variability and distinct, lineage-specific patterns of stem cell sensitivity to IFN-alpha were observed. In the erythroid series, the more primitive progenitor or burst-forming unit (BFU-E) was substantially more resistant to growth inhibition at low IFN-alpha concentrations than the mature colony-forming unit (CFU-E). Colony growth by the megakaryocyte progenitor cell (CFU-Meg) was decreased by all concentrations of IFN-alpha which produced a biphasic, inhibitory dose response. The response of the colony-forming unit granulocyte/macrophage (CFU-GM) was heterogeneous among the donors tested. CFU-GM growth from 2 donors was insensitive to IFN-alpha at all concentrations. Conversely, CFU-GM from the other 2 donors manifested a steep dose-response curve that was similar to that of the CFU-E. These data demonstrate a heterogeneity of progenitor cell sensitivity to growth suppression by IFN-alpha which appears to be influenced by (i) hematopoietic lineage, (ii) degree of differentiation of the progenitor cell, and (iii) individual variability.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3745985     DOI: 10.1089/jir.1986.6.199

Source DB:  PubMed          Journal:  J Interferon Res        ISSN: 0197-8357


  8 in total

1.  Interferon-α signaling promotes embryonic HSC maturation.

Authors:  Peter Geon Kim; Matthew C Canver; Catherine Rhee; Samantha J Ross; June V Harriss; Ho-Chou Tu; Stuart H Orkin; Haley O Tucker; George Q Daley
Journal:  Blood       Date:  2016-04-19       Impact factor: 22.113

2.  Effects of human alpha-interferon on granulocyte-macrophage progenitor cells (CFU-GM) in vitro.

Authors:  J S Schwamborn; R M Nickels; B D Katthagen; H W Pees; P G Scheurlen
Journal:  Blut       Date:  1988-03

3.  Globotriaosyl ceramide modulates interferon-alpha-induced growth inhibition and CD19 expression in Burkitt's lymphoma cells.

Authors:  M D Maloney; B Binnington-Boyd; C A Lingwood
Journal:  Glycoconj J       Date:  1999-12       Impact factor: 2.916

4.  Mechanisms of thrombocytopenia induced by interferon therapy for chronic hepatitis B.

Authors:  M Sata; Y Yano; Y Yoshiyama; T Ide; R Kumashiro; H Suzuki; K Tanikawa
Journal:  J Gastroenterol       Date:  1997-04       Impact factor: 7.527

5.  Megakaryopoiesis impairment through acute innate immune signaling activation by azacitidine.

Authors:  Komal K Javarappa; Dimitrios Tsallos; Joseph Saad; Ujunwa Cynthia Okoye-Okafor; Daozheng Yang; Chi Zhang; Lumie Benard; Victor J Thiruthuvanathan; Sally Cole; Stephen Ruiz; Madhuri Tatiparthy; Gaurav Choudhary; Stefanie DeFronzo; Boris A Bartholdy; Celine Pallaud; Pedro Marques Ramos; Aditi Shastri; Amit Verma; Caroline A Heckman; Britta Will
Journal:  J Exp Med       Date:  2022-09-02       Impact factor: 17.579

6.  Interferon α-induced SAMHD1 regulates human cultured megakaryocyte apoptosis and proplatelet formation.

Authors:  Seema Bhatlekar; Shancy Jacob; Emilia Tugolukova; Bhanu K Manne; Yasuhiro Kosaka; Phillipe Loher; Ryan M O'Connell; Vicente Planelles; Matthew T Rondina; Isidore Rigoutsos; Paul F Bray
Journal:  Haematologica       Date:  2022-02-01       Impact factor: 9.941

7.  Hemozoin (malarial pigment) directly promotes apoptosis of erythroid precursors.

Authors:  Abigail A Lamikanra; Michel Theron; Taco W A Kooij; David J Roberts
Journal:  PLoS One       Date:  2009-12-24       Impact factor: 3.240

Review 8.  Safety, Tolerability, and Immunogenicity of Interferons.

Authors:  Michael G Tovey; Christophe Lallemand
Journal:  Pharmaceuticals (Basel)       Date:  2010-04-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.